Interferon‐induced Mx proteins in brain tissue of multiple sclerosis patients
Authors:
- 28 April 2009
- journal article
- Published by Wiley in European Journal of Neurology
- Vol. 16 (6) , 721-726
Abstract
Background and purpose: Recombinant interferon‐beta is proven as an effective long‐term treatment in patients with multiple sclerosis (MS). Unlike in other chronic inflammatory diseases, endogenous synthesis of type I interferons (IFN‐alpha and IFN‐beta) has not been studied extensively in MS. Mx proteins A and B (MxA and MxB) are intracellular proteins that are induced exclusively by type I IFNs. We investigated the expression of Mx proteins in post‐mortem brain tissue of IFN‐beta‐naïve MS patients as a marker for endogenous synthesis of type I IFNs.Methods: By employing monoclonal antibodies specific for MxA and MxB positive staining was detectable predominantly in reactive astrocytes within the MS plaques but also in endothelial and ependymal cells as well as in lymphocytic infiltrates.Results: This is of interest in view of results previously published by our group and others that Mx protein concentrations measured by ELISA increase in blood samples from MS patients after IFN‐beta therapy.Conclusions: In MS, Mx proteins are detectable in plaques suggesting endogenous synthesis of type I IFNs as part of the acute inflammatory process.Keywords
This publication has 24 references indexed in Scilit:
- The Immunopathology of Multiple Sclerosis: An OverviewBrain Pathology, 2007
- Human MxB Protein, an Interferon-α-inducible GTPase, Contains a Nuclear Targeting Signal and Is Localized in the Heterochromatin Region beneath the Nuclear EnvelopeJournal of Biological Chemistry, 1996
- The virology of demyelinating diseasesAnnals of Neurology, 1994
- T Cells Responsive to Myelin Basic Protein in Patients with Multiple SclerosisScience, 1990
- The interferon-induced Mx-homologous protein in people with symptomatic HIV-1 infectionAIDS, 1990
- Multiple sclerosis: Involvement of interferons in lesion pathogenesisAnnals of Neurology, 1988
- IMMUNOREACTIVE α-INTERFERON IN INSULIN-SECRETING β CELLS IN TYPE 1 DIABETES MELLITUSThe Lancet, 1987
- INTERFERONS AND THEIR ACTIONSAnnual Review of Biochemistry, 1987
- EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERONThe Lancet, 1987
- Systemic Lupus Erythematosus: Presence in Human Serum of an Unusual Acid-Labile Leukocyte InterferonScience, 1982